Bortezomib for acute humoral rejection treatment at the Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán in Mexico City: an update. [electronic resource]
Producer: 20110708Description: 369-82 p. digitalISSN:- 0890-9016
- Academies and Institutes
- Acute Disease
- Adult
- Boronic Acids -- administration & dosage
- Bortezomib
- Drug Administration Schedule
- Female
- Graft Rejection -- immunology
- Graft Survival -- drug effects
- HLA Antigens -- immunology
- Humans
- Immunity, Humoral -- drug effects
- Immunosuppressive Agents -- administration & dosage
- Isoantibodies -- blood
- Kidney Transplantation -- immunology
- Male
- Mexico
- Middle Aged
- Plasmapheresis
- Protease Inhibitors -- administration & dosage
- Proteasome Endopeptidase Complex -- metabolism
- Proteasome Inhibitors
- Pyrazines -- administration & dosage
- Time Factors
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.